SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distrib...
SSY Group wins China NMPA approval for cimetidine injection registration
SSY Group wins China NMPA approval for sodium citrate hemofiltration replacement fluid
SSY Group says China grants NMPA registration approval for Gadobutrol bulk drug
SSY Group Wins China Approval for Next-Generation Lipid-Lowering Capsule
SSY Group wins China NMPA approval for choline fenofibrate sustained-release capsules
SSY Group says China regulator approves Baloxavir Marboxil bulk drug registration